Drugs & medicalClass II

Lupin Pharmaceuticals Inc. recalls Losartan Potassium Tablets USP, 100 mg, a) 90-count bottles (NDC# 68180-378-03), b) 1000-count bottles (NDC# 68180-378-09), Rx Only,…

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Read the official notice →
Date
2022-05-11
Country
United States
Brand
Lupin Pharmaceuticals
Product
Losartan Potassium Tablets USP, 100 mg, a) 90-count bottles (NDC# 68180-378-03), b) 1000-count bottles (NDC# 68180-378-09), Rx Only,…
Classification
Class II
Units
Product was distributed nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Lupin Pharmaceuticals recalls

  1. 2022-08-24
  2. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202…

    CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.

    FDA · DrugLupin Pharmaceuticals Inc.Product was distributed nationwide.Official notice →
  3. 2022-06-22
  4. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD…

    Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.

    FDA · DrugLupin Pharmaceuticals Inc.Product was distributed to 10 wholesalers/distributors and one mail order…Official notice →
  5. 2022-05-25
  6. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack NDC# 43386-060-19

    Failed Stability Specification

    FDA · DrugLupin Pharmaceuticals Inc.Product was distributed nationwide, including Puerto Rico.Official notice →
  7. 2022-01-12
  8. US
    Drugs & medicalClass III

    Lupin Pharmaceuticals Inc. recalls Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,…

    Out-of-specification impurity test result observed at 18-month long term stability time point.

    FDA · DrugLupin Pharmaceuticals Inc.Product Distributed in NY and OH.Official notice →
  9. US
    Drugs & medicalClass III

    Lupin Pharmaceuticals Inc. recalls Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC…

    Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

    FDA · DrugLupin Pharmaceuticals Inc.Nationwide in the USA and Puerto RicoOfficial notice →
  10. 2021-12-08
  11. US
All 38 Lupin Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2022-05-11
  2. US
    Drugs & medicalClass II

    McKesson Corporation dba McKesson Drug Company recalls Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL bottle, Rx only, Manufactured by: Teligent…

    CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

    FDA · DrugMcKesson Corporation dba McKesson Drug CompanyNationwide in the United States including Guam and the Northern Mariana Islands.Official notice →
  3. US
    Drugs & medicalClass III

    Akorn, Inc. recalls Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc.…

    Failed viscosity specification - product was below specificcation

    FDA · DrugAkorn, Inc.Nationwide USA and Puerto RicoOfficial notice →
  4. US
    Drugs & medicalClass II

    Viatris Inc recalls alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1.

    Failed Dissolution Specifications: low out-of-specification dissolution test results observed.

    FDA · DrugViatris IncProduct was distributed nationwide in the USAOfficial notice →
  5. US
    Drugs & medicalClass II

    Macleods Pharma Usa Inc recalls Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottles (NDC # 33342-045-07), b) 90-count bottles (NDC # 33342-045-10), c) 1000-count…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

    FDA · DrugMacleods Pharma Usa IncProduct was distributed nationwide.Official notice →
  6. US
    Drugs & medicalClass II

    SCA Pharmaceuticals recalls Vancomycin HCl 1.5 g in 0.9% Sodium Chloride, 500 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0924-44

    CGMP Deviations

    FDA · DrugSCA PharmaceuticalsProduct was distributed nationwide within the United StatesOfficial notice →
  7. 2022-05-04
  8. US
    Drugs & medicalClass II

    Freudenberg Medical, Llc recalls Empower Introducer Sheath with Hydrophilic Coating 21F x 56cm Model: 668782-100 (US)

    Non-intended glue from the hub/shaft bond on the inside ID of the catheter shaft may cause Embolism leading to peripheral ischemia

    FDA · DeviceFreudenberg Medical, LlcUS distribution: GA, OH Foreign distribution: NetherlandsOfficial notice →
See all drugs & medical recalls →